Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SRP6091

Sigma-Aldrich

FKBP1a/FKBP12 human

recombinant, expressed in E. coli, ≥95% (SDS-PAGE)

Synonym(s):

12 kDa FK506-binding protein, Calstabin-1, FK506 binding protein 1a, Immunophilin FKBP12, PPIase FKBP1A

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
UNSPSC Code:
12352204
NACRES:
NA.32

biological source

human

recombinant

expressed in E. coli

assay

≥95% (SDS-PAGE)

form

liquid

mol wt

14.1 kDa

packaging

pkg of 100 μg

NCBI accession no.

UniProt accession no.

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... FKBP1A(2280)

General description

FKBP1A is part of the family of immunophilins, which have in common high affinity for immunosuppressant drugs and a peptidyl-prolyl cis-trans isomerase (PPIase). In the absence of immunosuppressive ligands, FKBP1A is involved in intracellular calcium regulation by associating with 3 types of Ca2+ release channel complexes: skeletal ryanodine receptors, cardiac ryanodine receptors and the inositol 1, 4, 5-triphosphate receptor. FKBP1A also interacts with TGF type I receptor exerting an inhibitory effect on the TGF?-I signaling pathway. FKBP12 plays a role in modulation of ryanodine receptor isoform-1 (ryr-1), a component of the calcium release channel of skeletal muscle sarcoplasmic reticulum. FKBP1A increase the folding of proteins and catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.
FKFBP1A (FK506-binding protein 1A) belongs to the FK506-binding protein (FKBP) family. It is widely expressed in nerve systems. This gene is mapped to human chromosome 20p13. FKFBP1A interacts with various cellular molecules and participates in intracellular signaling pathways.

Biochem/physiol Actions

FKFBP1A (FK506-binding protein 1A) is a peptidyl-prolyl cis-trans isomerase. It interacts with the ryanodine receptor (RyR1) and helps in maintaining intracellular Ca2+ homeostasis. It is also involved in protein folding, cell cycle and protein trafficking. In neurodegenerative diseases, FKFBP1A is dysregulated and might be associated with the pathogenesis. In human cell lines, it controls the localization and processing of amyloid precursor protein, and thus might be involved in the pathogenesis of Alzheimer′s disease. FKFBP1A is also involved in Huntington′s disease. It plays a role in the structural properties and proteotoxicity of mHTT (mutant huntingtin) aggregates.

Physical form

1 mg/mL solution in 20 mM Tris-HCl buffer (pH 8.0) containing 100 mM NaCl, 1 mM DTT and 10% glycerol.

Preparation Note

Centrifuge the vial prior to opening.

Other Notes

MGSSHHHHHH SSGLVPRGSH MGVQVETISP GDGRTFPKRG QTCVVHYTGM LEDGKKFDSS RDRNKPFKFM LGKQEVIRGW EEGVAQMSVG QRAKLTISPD YAYGATGHPG IIPPHATLVF DVELLKLE

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines.
Liu FL, et al.
Journal of Biosciences, 39, 85-85 (2014)
Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.
Mazaira GI, et al.
International Journal of Cancer. Journal International Du Cancer, 138, 797-797 (2016)
Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect.
Sun CS, et al.
Scientific Reports, 5, 14992-14992 (2015)
Xuepei Zhang et al.
Journal of chromatography. A, 1359, 84-90 (2014-07-30)
A new approach for proteome-wide profiling drug binding proteins by using monolithic capillary affinity chromatography in combination with HPLC-MS/MS is reported. Two immunosuppresive drugs, namely FK506 and cyclosporin A, were utilized as the experimental models for proof-of-concept. The monolithic capillary

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service